The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidermal growth factor receptor: Mechanisms of activation and signalling
Jorissen, R. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00098-8 · Cited by 1,565
pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions.
Schaller, M. D., Borgman, C. A., Cobb, B. S., Vines, R. R., Reynolds, A. B., & Parsons, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.5192 · Cited by 1,444
Autophosphorylation of the Focal Adhesion Kinase, ppl25FAK, Directs SH2-Dependent Binding of pp60src
Schaller, M. D., Hildebrand, J. D., Shannon, J. D., Fox, J. W., Vines, R. R., & Parsons, J. T. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1680-1688.1994 · Cited by 1,138
Yeatman, T. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1366 · Cited by 1,113 · cited 1×
“Elevated Src activity has been implicated in promoting an aggressive tumour cell phenotype and thus Src presents itself as a potential therapeutic target for the prevention of tumour spread [22,28].”
BackgroundSchaller, M. D., Hildebrand, J. D., Shannon, J. D., Fox, J. W., Vines, R. R., & Parsons, J. T. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1680 · Cited by 876
Src family kinases in tumor progression and metastasis
Summy, J. M., & Gallick, G. E. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023772912750 · Cited by 827
Src family kinases are required for integrin but not PDGFR signal transduction
Klinghoffer, R. A., Sachsenmaier, C., Cooper, J. A., & Soriano, P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2459 · Cited by 731
Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration
Sieg, D. J., Hauck, C. R., & Schlaepfer, D. D. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.16.2677 · Cited by 687
Src in cancer: deregulation and consequences for cell behaviour
Frame, M. C. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00040-9 · Cited by 683
Biscardi, J. S., Maa, M.-C., Tice, D. A., Cox, M. E., Leu, T.-H., & Parsons, S. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8335 · Cited by 649
Knowlden, J. M., Hutcheson, I. R., Jones, H. E., Madden, T., Gee, J. M. W., Harper, M. E., Barrow, D., Wakeling, A. E., & Nicholson, R. I. (2003) · Endocrinology · doi:10.1210/en.2002-220620 · Cited by 521
Self-citationGilmore, A. P., & Romer, L. H. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.8.1209 · Cited by 513
Why the Epidermal Growth Factor Receptor? The Rationale for Cancer Therapy
Baselga, J. (2002) · The Oncologist · doi:10.1634/theoncologist.7-2004-2 · Cited by 510
Mechanism of biological synergy between cellular Src and epidermal growth factor receptor
Tice, D. A., Biscardi, J. S., Nickles, A. L., & Parsons, S. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1415 · Cited by 472
Control of motile and invasive cell phenotypes by focal adhesion kinase
Schlaepfer, D. D., Mitra, S. K., & Ilic, D. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.04.008 · Cited by 440
Owen, J. D., Ruest, P. J., Fry, D. W., & Hanks, S. K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4806 · Cited by 396
Moro, L., Dolce, L., Cabodi, S., Bergatto, E., Erba, E. B., Smeriglio, M., Turco, E., Retta, S. F., Giuffrida, M. G., Venturino, M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109101200 · Cited by 377
Hanks, S. K. (2003) · Frontiers in Bioscience · doi:10.2741/1114 · Cited by 366
Turner, C. E. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.23.4139 · Cited by 363
Characterization of Tyrosine Phosphorylation of Paxillin in Vitro by Focal Adhesion Kinase
Bellis, S. L., Miller, J. T., & Turner, C. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17437 · Cited by 333
Maa, M. C., Leu, T. H., McCarley, D. J., Schatzman, R. C., & Parsons, S. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6981 · Cited by 330
c-Src enhances the spreading of src-/- fibroblasts on fibronectin by a kinase-independent mechanism.
Kaplan, K. B., Swedlow, J. R., Morgan, D. O., & Varmus, H. E. (1995) · Genes & Development · doi:10.1101/gad.9.12.1505 · Cited by 317
Schiff, R., Massarweh, S. A., Shou, J., & Osborne, C. K. (2003) · PubMed · Cited by 304
Fincham, V. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.81 · Cited by 289
Petit, V., Boyer, B., Lentz, D., Turner, C. E., Thiery, J. P., & Vallés, A. M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.5.957 · Cited by 279
Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src−/− mutant mice
Schwartzberg, P. L., Xing, L., Hoffmann, O., Lowell, C. A., Garrett, L., Boyce, B. F., & Varmus, H. E. (1997) · Genes & Development · doi:10.1101/gad.11.21.2835 · Cited by 268
Activation of Src kinase in primary colorectal carcinoma: An indicator of poor clinical prognosis
Allgayer, H., Boyd, D. D., Heiss, M. M., Abdalla, E. K., Curley, S. A., & Gallick, G. E. (2002) · Cancer · doi:10.1002/cncr.10221 · Cited by 251 · cited 1×
“Additionally, levels of both Src protein and Src kinase activity may be elevated in human neoplastic tissues compared to adjacent normal tissues and in some cases, the level of Src activity appears to correlate with disease stage [24,32,33].”
BackgroundRoche, S., Koegl, M., Barone, M. V., Roussel, M. F., & Courtneidge, S. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.1102 · Cited by 244
Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity.
Muthuswamy, S. K., Siegel, P. M., Dankort, D. L., Webster, M. A., & Muller, W. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.735 · Cited by 228
Boerner, J. L., Demory, M. L., Silva, C., & Parsons, S. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7059-7071.2004 · Cited by 213
Mao, W., Irby, R., Coppola, D., Fu, L., Wloch, M., Turner, J., Yu, H., Garcia, R., Jove, R., & Yeatman, T. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201496 · Cited by 200 · cited 1×
“Elevated Src kinase activity has also been observed in highly metastatic cells when compared to poorly metastatic cells and in tissues from cancer patients [34].”
BackgroundTargeting the epidermal growth factor receptor
El-Rayes, B. F., & LoRusso, P. M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601921 · Cited by 184
Activated Src Protein Tyrosine Kinase Is Overexpressed in Late-Stage Human Ovarian Cancers
Wiener, J. R., Windham, T. C., Estrella, V. C., Parikh, N. U., Thall, P. F., Deavers, M. T., Bast, R. C., Mills, G. B., & Gallick, G. E. (2003) · Gynecologic Oncology · doi:10.1006/gyno.2002.6851 · Cited by 175
Plé, P. A., Green, T. P., Hennequin, L. F., Curwen, J., Fennell, M., Allen, J., Lambert-van der Brempt, C., & Costello, G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030317k · Cited by 169
Self-citationSTAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor
Kloth, M. T., Laughlin, K. K., Biscardi, J. S., Boerner, J. L., Parsons, S. J., & Silva, C. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207289200 · Cited by 166
Biscardi, J. S., Belsches, A. P., & Parsons, S. J. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199804)21:4<261::aid-mc5>3.0.co;2-n · Cited by 165
Src and Ras are involved in separate pathways in epithelial cell scattering
Boyer, B., Roche, S., Denoyelle, M., & Thiery, J. P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.19.5904 · Cited by 155
Irby, R., & Yeatman, T. J. (2002) · PubMed · Cited by 125
Src kinase contributes to the metastatic spread of carcinoma cells
Boyer, B., Bourgeois, Y., & Poupon, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205298 · Cited by 123
Hiscox, S., Morgan, L. D., Barrow, D., Dutkowski, C. M., Wakeling, A. E., & Nicholson, R. I. (2004) · Clinical & Experimental Metastasis · doi:10.1023/b:clin.0000037697.76011.1d · Cited by 121
Self-citationpp60c-src activation in lung adenocarcinoma
Masaki, T., Igarashi, K., Tokuda, M., Yukimasa, S., Han, F., Jin, Y. J., Li, J. Q., Yoneyama, H., Uchida, N., Fujita, J., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00276-4 · Cited by 114
Wilson, L. K., Luttrell, D. K., Parsons, J. T., & Parsons, S. J. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.4.1536 · Cited by 107
Functional implication of the interaction between EGF receptor and C-SRC
Leu, T., & Maa, M.-C. (2003) · Frontiers in bioscience · doi:10.2741/980 · Cited by 81
Jones, R. J., Avizienyte, E., Wyke, A. W., Owens, D. W., Brunton, V. G., & Frame, M. C. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600594 · Cited by 80 · cited 2×
“Src is also a key element in the regulation of integrin-dependent attachment, acting in conjunction with focal adhesion kinase (FAK) to regulate focal adhesion turnover and cell migration [18,19].”
Backgroundpp60c-src Activation in hepatocellular carcinoma of humans and LEC rats
Masaki, T., Okada, M., Shiratori, Y., Rengifo, W., Matsumoto, K., Maeda, S., Kato, N., Kanai, F., Komatsu, Y., Nishioka, M., et al. (1998) · Hepatology · doi:10.1002/hep.510270511 · Cited by 79
Sato, K., Nagao, T., Iwasaki, T., Nishihira, Y., & Fukami, Y. (2003) · Genes to Cells · doi:10.1046/j.1356-9597.2003.00691.x · Cited by 76
Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice
Nishikawa, M., Tamada, A., Hyoudou, K., Umeyama, Y., Takahashi, Y., Kobayashi, Y., Kumai, H., Ishida, E., Štaud, F., Yabe, Y., et al. (2004) · Clinical & Experimental Metastasis · doi:10.1023/b:clin.0000037706.13747.5e · Cited by 65
Endocrine-resistant breast cancer: Underlying mechanisms and strategies for overcoming resistance
Kurebayashi, J. (2003) · Breast Cancer · doi:10.1007/bf02967635 · Cited by 54
Overexpression of pp60c-src elicits invasive behavior in rat colon epithelial cells
Pories, S. E., Hess, D. T., Swenson, K. K., Lotz, M. M., Moussa, R., Steele, G. D., Shibata, D., Rieger‐Christ, K., & Summerhayes, I. C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70435-4 · Cited by 34
Activation of c-Src is Inversely Correlated with Biological Aggressiveness of Breast Carcinoma
Ito, Y., Kawakatsu, H., Takeda, T., Tani, N., Kawaguchi, N., Noguchi, S., Sakai, T., & Matsuura∥, N. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1020860221099 · Cited by 27
Romanova, L. Y., Hashimoto, S., Chay, K.-O., Blagosklonny, M. V., Sabe, H., & Mushinski, J. F. (2004) · Journal of Cell Science · doi:10.1242/jcs.01206 · Cited by 27
Cited by
Triple-negative breast cancer: disease entity or title of convenience?
Carey, L., Winer, E., Viale, G., Cameron, D., & Gianni, L. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.154 · Cited by 783
Src kinases as therapeutic targets for cancer
Kim, L. C., Song, L., & Haura, E. B. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.129 · Cited by 700
Banerjee, M., Cui, X., Li, Z., Yu, H., Cai, L., Jia, X., He, D., Wang, C., Gao, T., & Xie, Z. (2018) · Scientific Reports · doi:10.1038/s41598-018-29995-2 · Cited by 506
Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis
Reiter, R., Rosales-Corral, S., Tan, D.-X., Acuna-Castroviejo, D., Qin, L., Yang, S.-F., & Xu, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040843 · Cited by 433
p27 Phosphorylation by Src Regulates Inhibition of Cyclin E-Cdk2
Chu, I., Sun, J., Arnaout, A., Kahn, H., Hanna, W., Narod, S., Sun, P., Tan, C.-K., Hengst, L., & Slingerland, J. (2007) · Cell · doi:10.1016/j.cell.2006.11.049 · Cited by 372
Metadata
- Authors
- Hiscox, S., Morgan, L., Green, T. P., Barrow, D., Gee, J., & Nicholson, R. I.
- Venue
- Breast Cancer Research and Treatment
- Published
- 2005-12-07
- Volume
- 97
- Issue
- 3
- Pages
- 263-274
- ISSN
- 0167-6806 (ISSN-L)
- 1573-7217
- OpenAlex
- W2045792003
- Cited by
- 274
- References
- 51
- FWCI
- 17.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.